img

Global Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Influenza Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
Influenza Vaccine report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Influenza Vaccine market is projected to reach US$ 10950 million in 2034, increasing from US$ 7599.8 million in 2022, with the CAGR of 5.3% during the period of 2024 to 2034. Demand from 6 Months to 3 Years and > 3 Years are the major drivers for the industry.
Global influenza vaccine main players include CSL, GSK, Sanofi Pasteur, AstraZeneca etc.The top 5 account for about 95% of market. North America is the largest market of influenza vaccine, with a share about 45%. As for the types of products, it can be divided into trivalent influenza vaccine and quadrivalent influenza vaccine. The most common product is quadrivalent influenza vaccine, with a share over 90%. In terms of applications, it is widely used in for children (6 months to 3 years) and For adults and children over 3 years. The most application is in adults and children over 3 years, with a share over 80%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine

Segment by Application


6 Months to 3 Years
> 3 Years

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Influenza Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Influenza Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Influenza Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Influenza Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Influenza Vaccine introduction, etc. Influenza Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Influenza Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Influenza Vaccine Market Overview
1.1 Influenza Vaccine Product Overview
1.2 Influenza Vaccine Market Segment by Type
1.2.1 Trivalent Influenza Vaccine
1.2.2 Quadrivalent Influenza Vaccine
1.3 Global Influenza Vaccine Market Size by Type
1.3.1 Global Influenza Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Influenza Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Influenza Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Influenza Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Influenza Vaccine Sales Breakdown by Type (2018-2024)
2 Global Influenza Vaccine Market Competition by Company
2.1 Global Top Players by Influenza Vaccine Sales (2018-2024)
2.2 Global Top Players by Influenza Vaccine Revenue (2018-2024)
2.3 Global Top Players by Influenza Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Influenza Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Vaccine Market Competitive Situation and Trends
2.5.1 Influenza Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Vaccine Market
2.8 Key Manufacturers Influenza Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Vaccine Status and Outlook by Region
3.1 Global Influenza Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Influenza Vaccine Historic Market Size by Region
3.2.1 Global Influenza Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Influenza Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Influenza Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Influenza Vaccine Forecasted Market Size by Region
3.3.1 Global Influenza Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Influenza Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Influenza Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Influenza Vaccine by Application
4.1 Influenza Vaccine Market Segment by Application
4.1.1 6 Months to 3 Years
4.1.2 > 3 Years
4.2 Global Influenza Vaccine Market Size by Application
4.2.1 Global Influenza Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Influenza Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Influenza Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Influenza Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Influenza Vaccine Sales Breakdown by Application (2018-2024)
5 North America Influenza Vaccine by Country
5.1 North America Influenza Vaccine Historic Market Size by Country
5.1.1 North America Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Influenza Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Influenza Vaccine Sales in Value by Country (2018-2024)
5.2 North America Influenza Vaccine Forecasted Market Size by Country
5.2.1 North America Influenza Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Influenza Vaccine Sales in Value by Country (2024-2034)
6 Europe Influenza Vaccine by Country
6.1 Europe Influenza Vaccine Historic Market Size by Country
6.1.1 Europe Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Influenza Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Influenza Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Influenza Vaccine Forecasted Market Size by Country
6.2.1 Europe Influenza Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Influenza Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Influenza Vaccine by Region
7.1 Asia-Pacific Influenza Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Influenza Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Influenza Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Influenza Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Influenza Vaccine Sales in Value by Region (2024-2034)
8 Latin America Influenza Vaccine by Country
8.1 Latin America Influenza Vaccine Historic Market Size by Country
8.1.1 Latin America Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Influenza Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Influenza Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Influenza Vaccine Forecasted Market Size by Country
8.2.1 Latin America Influenza Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Influenza Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Influenza Vaccine by Country
9.1 Middle East and Africa Influenza Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Influenza Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Influenza Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Influenza Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Influenza Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Influenza Vaccine Products Offered
10.1.5 Sanofi Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CSL Influenza Vaccine Products Offered
10.2.5 CSL Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 GSK Influenza Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Viatris
10.4.1 Viatris Company Information
10.4.2 Viatris Introduction and Business Overview
10.4.3 Viatris Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Viatris Influenza Vaccine Products Offered
10.4.5 Viatris Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Influenza Vaccine Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Hualan Bio
10.6.1 Hualan Bio Company Information
10.6.2 Hualan Bio Introduction and Business Overview
10.6.3 Hualan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Hualan Bio Influenza Vaccine Products Offered
10.6.5 Hualan Bio Recent Development
10.7 Changchun Institute of Biological
10.7.1 Changchun Institute of Biological Company Information
10.7.2 Changchun Institute of Biological Introduction and Business Overview
10.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Changchun Institute of Biological Influenza Vaccine Products Offered
10.7.5 Changchun Institute of Biological Recent Development
10.8 Sinovac
10.8.1 Sinovac Company Information
10.8.2 Sinovac Introduction and Business Overview
10.8.3 Sinovac Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Sinovac Influenza Vaccine Products Offered
10.8.5 Sinovac Recent Development
10.9 BCHT
10.9.1 BCHT Company Information
10.9.2 BCHT Introduction and Business Overview
10.9.3 BCHT Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 BCHT Influenza Vaccine Products Offered
10.9.5 BCHT Recent Development
10.10 Jiangsu GDK
10.10.1 Jiangsu GDK Company Information
10.10.2 Jiangsu GDK Introduction and Business Overview
10.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Jiangsu GDK Influenza Vaccine Products Offered
10.10.5 Jiangsu GDK Recent Development
10.11 KM Biologics
10.11.1 KM Biologics Company Information
10.11.2 KM Biologics Introduction and Business Overview
10.11.3 KM Biologics Influenza Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 KM Biologics Influenza Vaccine Products Offered
10.11.5 KM Biologics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Vaccine Industrial Chain Analysis
11.4 Influenza Vaccine Market Dynamics
11.4.1 Influenza Vaccine Industry Trends
11.4.2 Influenza Vaccine Market Drivers
11.4.3 Influenza Vaccine Market Challenges
11.4.4 Influenza Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Vaccine Distributors
12.3 Influenza Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Trivalent Influenza Vaccine
Table 2. Major Company of Quadrivalent Influenza Vaccine
Table 3. Global Influenza Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Influenza Vaccine Sales by Type (2018-2024) & (M Doses)
Table 5. Global Influenza Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Influenza Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Influenza Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Influenza Vaccine Price by Type (2018-2024) & (USD/Doses)
Table 9. Global Influenza Vaccine Sales by Type (2024-2034) & (M Doses)
Table 10. Global Influenza Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Influenza Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Influenza Vaccine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Influenza Vaccine Price by Type (2024-2034) & (USD/Doses)
Table 14. North America Influenza Vaccine Sales by Type (2018-2024) & (M Doses)
Table 15. North America Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Influenza Vaccine Sales (M Doses) by Type (2018-2024)
Table 17. Europe Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Influenza Vaccine Sales (M Doses) by Type (2018-2024)
Table 19. Asia-Pacific Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Influenza Vaccine Sales (M Doses) by Type (2018-2024)
Table 21. Latin America Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Influenza Vaccine Sales (M Doses) by Type (2018-2024)
Table 23. Middle East and Africa Influenza Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Influenza Vaccine Sales by Company (2018-2024) & (M Doses)
Table 25. Global Influenza Vaccine Sales Share by Company (2018-2024)
Table 26. Global Influenza Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Influenza Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Influenza Vaccine Price by Company (2018-2024) & (USD/Doses)
Table 29. Global Influenza Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Influenza Vaccine Market
Table 33. Key Manufacturers Influenza Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Influenza Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Influenza Vaccine Sales by Region (2018-2024) & (M Doses)
Table 37. Global Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2024)
Table 41. Global Influenza Vaccine Sales by Region (2024-2034) & (M Doses)
Table 42. Global Influenza Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Influenza Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Influenza Vaccine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2024-2034)
Table 46. Global Influenza Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Influenza Vaccine Sales by Application (2018-2024) & (M Doses)
Table 48. Global Influenza Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Influenza Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Influenza Vaccine Price by Application (2018-2024) & (USD/Doses)
Table 52. Global Influenza Vaccine Sales by Application (2024-2034) & (M Doses)
Table 53. Global Influenza Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Influenza Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Influenza Vaccine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Influenza Vaccine Price by Application (2024-2034) & (USD/Doses)
Table 57. North America Influenza Vaccine Sales by Application (2018-2024) (M Doses)
Table 58. North America Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Influenza Vaccine Sales by Application (2018-2024) (M Doses)
Table 60. Europe Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Influenza Vaccine Sales by Application (2018-2024) (M Doses)
Table 62. Asia-Pacific Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Influenza Vaccine Sales by Application (2018-2024) (M Doses)
Table 64. Latin America Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Influenza Vaccine Sales by Application (2018-2024) (M Doses)
Table 66. Middle East and Africa Influenza Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Influenza Vaccine Sales by Country (2018-2024) & (M Doses)
Table 68. North America Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Influenza Vaccine Sales by Country (2024-2034) & (M Doses)
Table 72. North America Influenza Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Influenza Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Influenza Vaccine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Influenza Vaccine Sales by Country (2018-2024) & (M Doses)
Table 76. Europe Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Influenza Vaccine Sales by Country (2024-2034) & (M Doses)
Table 80. Europe Influenza Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Influenza Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Influenza Vaccine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Influenza Vaccine Sales by Region (2018-2024) & (M Doses)
Table 84. Asia-Pacific Influenza Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Influenza Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Influenza Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Influenza Vaccine Sales by Region (2024-2034) & (M Doses)
Table 88. Asia-Pacific Influenza Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Influenza Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Influenza Vaccine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Influenza Vaccine Sales by Country (2018-2024) & (M Doses)
Table 92. Latin America Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Influenza Vaccine Sales by Country (2024-2034) & (M Doses)
Table 96. Latin America Influenza Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Influenza Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Influenza Vaccine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Influenza Vaccine Sales by Country (2018-2024) & (M Doses)
Table 100. Middle East and Africa Influenza Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Influenza Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Influenza Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Influenza Vaccine Sales by Country (2024-2034) & (M Doses)
Table 104. Middle East and Africa Influenza Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Influenza Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Influenza Vaccine Sales Market Share in Value by Country (2024-2034)
Table 107. Sanofi Company Information
Table 108. Sanofi Introduction and Business Overview
Table 109. Sanofi Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 110. Sanofi Influenza Vaccine Product
Table 111. Sanofi Recent Development
Table 112. CSL Company Information
Table 113. CSL Introduction and Business Overview
Table 114. CSL Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 115. CSL Influenza Vaccine Product
Table 116. CSL Recent Development
Table 117. GSK Company Information
Table 118. GSK Introduction and Business Overview
Table 119. GSK Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 120. GSK Influenza Vaccine Product
Table 121. GSK Recent Development
Table 122. Viatris Company Information
Table 123. Viatris Introduction and Business Overview
Table 124. Viatris Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 125. Viatris Influenza Vaccine Product
Table 126. Viatris Recent Development
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Introduction and Business Overview
Table 129. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 130. AstraZeneca Influenza Vaccine Product
Table 131. AstraZeneca Recent Development
Table 132. Hualan Bio Company Information
Table 133. Hualan Bio Introduction and Business Overview
Table 134. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 135. Hualan Bio Influenza Vaccine Product
Table 136. Hualan Bio Recent Development
Table 137. Changchun Institute of Biological Company Information
Table 138. Changchun Institute of Biological Introduction and Business Overview
Table 139. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 140. Changchun Institute of Biological Influenza Vaccine Product
Table 141. Changchun Institute of Biological Recent Development
Table 142. Sinovac Company Information
Table 143. Sinovac Introduction and Business Overview
Table 144. Sinovac Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 145. Sinovac Influenza Vaccine Product
Table 146. Sinovac Recent Development
Table 147. BCHT Company Information
Table 148. BCHT Introduction and Business Overview
Table 149. BCHT Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 150. BCHT Influenza Vaccine Product
Table 151. BCHT Recent Development
Table 152. Jiangsu GDK Company Information
Table 153. Jiangsu GDK Introduction and Business Overview
Table 154. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 155. Jiangsu GDK Influenza Vaccine Product
Table 156. Jiangsu GDK Recent Development
Table 157. KM Biologics Company Information
Table 158. KM Biologics Introduction and Business Overview
Table 159. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Doses) and Gross Margin (2018-2024)
Table 160. KM Biologics Influenza Vaccine Product
Table 161. KM Biologics Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Influenza Vaccine Market Trends
Table 165. Influenza Vaccine Market Drivers
Table 166. Influenza Vaccine Market Challenges
Table 167. Influenza Vaccine Market Restraints
Table 168. Influenza Vaccine Distributors List
Table 169. Influenza Vaccine Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Global Influenza Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Influenza Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Influenza Vaccine Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of Trivalent Influenza Vaccine
Figure 6. Global Trivalent Influenza Vaccine Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Quadrivalent Influenza Vaccine
Figure 8. Global Quadrivalent Influenza Vaccine Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Global Influenza Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Influenza Vaccine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Influenza Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Influenza Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza Vaccine Revenue in 2022
Figure 23. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of 6 Months to 3 Years
Figure 25. Global 6 Months to 3 Years Sales YoY Growth (2018-2034) & (M Doses)
Figure 26. Product Picture of > 3 Years
Figure 27. Global > 3 Years Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Global Influenza Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Influenza Vaccine Sales Market Share by Application in 2022 & 2034
Figure 30. North America Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Influenza Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Influenza Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Influenza Vaccine Manufacturing Cost Structure
Figure 41. Influenza Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries